nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—CYP2B6—Thiotepa—urinary bladder cancer	0.0907	0.184	CbGbCtD
Amitriptyline—ABCB1—Mitomycin—urinary bladder cancer	0.0613	0.124	CbGbCtD
Amitriptyline—ALB—Fluorouracil—urinary bladder cancer	0.0289	0.0586	CbGbCtD
Amitriptyline—CYP3A4—Thiotepa—urinary bladder cancer	0.0279	0.0565	CbGbCtD
Amitriptyline—CYP2B6—Cisplatin—urinary bladder cancer	0.025	0.0508	CbGbCtD
Amitriptyline—CYP2E1—Etoposide—urinary bladder cancer	0.0249	0.0506	CbGbCtD
Amitriptyline—ADRA1B—vas deferens—urinary bladder cancer	0.0234	0.146	CbGeAlD
Amitriptyline—CYP2C8—Fluorouracil—urinary bladder cancer	0.0223	0.0453	CbGbCtD
Amitriptyline—CYP3A5—Etoposide—urinary bladder cancer	0.0194	0.0393	CbGbCtD
Amitriptyline—CYP2C8—Etoposide—urinary bladder cancer	0.0186	0.0378	CbGbCtD
Amitriptyline—ABCB1—Gemcitabine—urinary bladder cancer	0.0177	0.0358	CbGbCtD
Amitriptyline—CYP1A2—Fluorouracil—urinary bladder cancer	0.0173	0.035	CbGbCtD
Amitriptyline—CYP2B6—Doxorubicin—urinary bladder cancer	0.0168	0.034	CbGbCtD
Amitriptyline—ALB—Methotrexate—urinary bladder cancer	0.0159	0.0323	CbGbCtD
Amitriptyline—CYP2C9—Fluorouracil—urinary bladder cancer	0.0156	0.0316	CbGbCtD
Amitriptyline—CYP1A2—Etoposide—urinary bladder cancer	0.0144	0.0292	CbGbCtD
Amitriptyline—HTR7—vas deferens—urinary bladder cancer	0.0136	0.085	CbGeAlD
Amitriptyline—CYP2C9—Cisplatin—urinary bladder cancer	0.0132	0.0268	CbGbCtD
Amitriptyline—ABCB1—Cisplatin—urinary bladder cancer	0.0128	0.026	CbGbCtD
Amitriptyline—ABCB1—Etoposide—urinary bladder cancer	0.0126	0.0256	CbGbCtD
Amitriptyline—CHRM3—ureter—urinary bladder cancer	0.011	0.0684	CbGeAlD
Amitriptyline—ABCB1—Doxorubicin—urinary bladder cancer	0.0086	0.0174	CbGbCtD
Amitriptyline—ABCB1—Methotrexate—urinary bladder cancer	0.00833	0.0169	CbGbCtD
Amitriptyline—CYP2D6—Doxorubicin—urinary bladder cancer	0.0081	0.0164	CbGbCtD
Amitriptyline—CHRM3—muscle of abdomen—urinary bladder cancer	0.00788	0.0492	CbGeAlD
Amitriptyline—CYP3A4—Etoposide—urinary bladder cancer	0.00755	0.0153	CbGbCtD
Amitriptyline—NTRK2—prostate gland—urinary bladder cancer	0.00533	0.0333	CbGeAlD
Amitriptyline—CYP3A4—Doxorubicin—urinary bladder cancer	0.00515	0.0104	CbGbCtD
Amitriptyline—Olopatadine—S100B—urinary bladder cancer	0.00357	0.855	CrCbGaD
Amitriptyline—CYP2C19—urine—urinary bladder cancer	0.00331	0.0207	CbGeAlD
Amitriptyline—KCND3—prostate gland—urinary bladder cancer	0.00307	0.0192	CbGeAlD
Amitriptyline—NTRK2—female reproductive system—urinary bladder cancer	0.00291	0.0182	CbGeAlD
Amitriptyline—CYP1A2—urine—urinary bladder cancer	0.0027	0.0169	CbGeAlD
Amitriptyline—CYP2C9—urine—urinary bladder cancer	0.00256	0.016	CbGeAlD
Amitriptyline—CYP2E1—urine—urinary bladder cancer	0.00243	0.0152	CbGeAlD
Amitriptyline—OPRK1—prostate gland—urinary bladder cancer	0.00242	0.0151	CbGeAlD
Amitriptyline—KCNQ3—female reproductive system—urinary bladder cancer	0.0022	0.0138	CbGeAlD
Amitriptyline—HTR2A—urine—urinary bladder cancer	0.00211	0.0132	CbGeAlD
Amitriptyline—ADRA1D—prostate gland—urinary bladder cancer	0.00204	0.0127	CbGeAlD
Amitriptyline—KCNQ2—female reproductive system—urinary bladder cancer	0.00203	0.0127	CbGeAlD
Amitriptyline—CYP3A4—urine—urinary bladder cancer	0.00196	0.0122	CbGeAlD
Amitriptyline—CYP2D6—urine—urinary bladder cancer	0.00192	0.012	CbGeAlD
Amitriptyline—OPRD1—renal system—urinary bladder cancer	0.00172	0.0108	CbGeAlD
Amitriptyline—NTRK2—lymph node—urinary bladder cancer	0.0017	0.0106	CbGeAlD
Amitriptyline—ORM1—prostate gland—urinary bladder cancer	0.00168	0.0105	CbGeAlD
Amitriptyline—CHRM5—epithelium—urinary bladder cancer	0.00168	0.0105	CbGeAlD
Amitriptyline—CHRM2—prostate gland—urinary bladder cancer	0.00157	0.00979	CbGeAlD
Amitriptyline—ADRA1D—epithelium—urinary bladder cancer	0.0015	0.00937	CbGeAlD
Amitriptyline—CHRM1—prostate gland—urinary bladder cancer	0.00143	0.00891	CbGeAlD
Amitriptyline—SIGMAR1—prostate gland—urinary bladder cancer	0.00142	0.00889	CbGeAlD
Amitriptyline—ADRA1B—renal system—urinary bladder cancer	0.00142	0.00888	CbGeAlD
Amitriptyline—ADRA1D—urethra—urinary bladder cancer	0.00137	0.00854	CbGeAlD
Amitriptyline—OPRK1—female reproductive system—urinary bladder cancer	0.00132	0.00825	CbGeAlD
Amitriptyline—CHRM3—prostate gland—urinary bladder cancer	0.00128	0.00798	CbGeAlD
Amitriptyline—SIGMAR1—seminal vesicle—urinary bladder cancer	0.0012	0.00752	CbGeAlD
Amitriptyline—ADRA1A—prostate gland—urinary bladder cancer	0.00117	0.00732	CbGeAlD
Amitriptyline—ADRA1D—female reproductive system—urinary bladder cancer	0.00111	0.00696	CbGeAlD
Amitriptyline—SIGMAR1—smooth muscle tissue—urinary bladder cancer	0.00101	0.00629	CbGeAlD
Amitriptyline—KCND3—lymph node—urinary bladder cancer	0.00098	0.00612	CbGeAlD
Amitriptyline—SIGMAR1—urethra—urinary bladder cancer	0.000953	0.00595	CbGeAlD
Amitriptyline—CYP3A5—prostate gland—urinary bladder cancer	0.000935	0.00584	CbGeAlD
Amitriptyline—ORM1—female reproductive system—urinary bladder cancer	0.000918	0.00573	CbGeAlD
Amitriptyline—HRH1—prostate gland—urinary bladder cancer	0.000908	0.00567	CbGeAlD
Amitriptyline—CHRM3—smooth muscle tissue—urinary bladder cancer	0.000904	0.00565	CbGeAlD
Amitriptyline—HTR7—epithelium—urinary bladder cancer	0.000893	0.00558	CbGeAlD
Amitriptyline—ADRA2A—prostate gland—urinary bladder cancer	0.000892	0.00557	CbGeAlD
Amitriptyline—CYP2E1—prostate gland—urinary bladder cancer	0.000872	0.00545	CbGeAlD
Amitriptyline—CHRM3—renal system—urinary bladder cancer	0.000871	0.00544	CbGeAlD
Amitriptyline—HTR1A—renal system—urinary bladder cancer	0.000867	0.00541	CbGeAlD
Amitriptyline—ADRA1A—epithelium—urinary bladder cancer	0.000862	0.00538	CbGeAlD
Amitriptyline—HTR7—smooth muscle tissue—urinary bladder cancer	0.000861	0.00538	CbGeAlD
Amitriptyline—HTR1B—female reproductive system—urinary bladder cancer	0.000861	0.00537	CbGeAlD
Amitriptyline—CHRM3—urethra—urinary bladder cancer	0.000855	0.00534	CbGeAlD
Amitriptyline—HTR1D—female reproductive system—urinary bladder cancer	0.000833	0.0052	CbGeAlD
Amitriptyline—HTR7—renal system—urinary bladder cancer	0.000829	0.00517	CbGeAlD
Amitriptyline—HTR2C—female reproductive system—urinary bladder cancer	0.000825	0.00515	CbGeAlD
Amitriptyline—ADRA1A—renal system—urinary bladder cancer	0.000799	0.00499	CbGeAlD
Amitriptyline—SLC6A4—female reproductive system—urinary bladder cancer	0.000782	0.00488	CbGeAlD
Amitriptyline—CHRM1—female reproductive system—urinary bladder cancer	0.000779	0.00487	CbGeAlD
Amitriptyline—HRH2—lymph node—urinary bladder cancer	0.000764	0.00477	CbGeAlD
Amitriptyline—ADRA2A—seminal vesicle—urinary bladder cancer	0.000754	0.00471	CbGeAlD
Amitriptyline—CYP2E1—seminal vesicle—urinary bladder cancer	0.000738	0.00461	CbGeAlD
Amitriptyline—CYP2C8—renal system—urinary bladder cancer	0.000706	0.00441	CbGeAlD
Amitriptyline—SIGMAR1—vagina—urinary bladder cancer	0.000703	0.00439	CbGeAlD
Amitriptyline—CHRM3—female reproductive system—urinary bladder cancer	0.000697	0.00435	CbGeAlD
Amitriptyline—SLC6A2—female reproductive system—urinary bladder cancer	0.000689	0.0043	CbGeAlD
Amitriptyline—HRH1—epithelium—urinary bladder cancer	0.000667	0.00417	CbGeAlD
Amitriptyline—HTR7—female reproductive system—urinary bladder cancer	0.000664	0.00414	CbGeAlD
Amitriptyline—CYP1A2—renal system—urinary bladder cancer	0.000661	0.00413	CbGeAlD
Amitriptyline—HRH1—smooth muscle tissue—urinary bladder cancer	0.000643	0.00401	CbGeAlD
Amitriptyline—CYP3A5—renal system—urinary bladder cancer	0.000638	0.00398	CbGeAlD
Amitriptyline—CYP2B6—renal system—urinary bladder cancer	0.000634	0.00396	CbGeAlD
Amitriptyline—HRH1—urethra—urinary bladder cancer	0.000608	0.0038	CbGeAlD
Amitriptyline—Clomipramine—GSTP1—urinary bladder cancer	0.000606	0.145	CrCbGaD
Amitriptyline—ADRA2A—urethra—urinary bladder cancer	0.000597	0.00373	CbGeAlD
Amitriptyline—CYP2E1—renal system—urinary bladder cancer	0.000595	0.00371	CbGeAlD
Amitriptyline—CYP2C19—vagina—urinary bladder cancer	0.000586	0.00366	CbGeAlD
Amitriptyline—CYP2E1—urethra—urinary bladder cancer	0.000584	0.00365	CbGeAlD
Amitriptyline—CYP2C8—female reproductive system—urinary bladder cancer	0.000566	0.00353	CbGeAlD
Amitriptyline—HTR2A—epithelium—urinary bladder cancer	0.000557	0.00348	CbGeAlD
Amitriptyline—ORM1—lymph node—urinary bladder cancer	0.000537	0.00335	CbGeAlD
Amitriptyline—HTR2A—smooth muscle tissue—urinary bladder cancer	0.000537	0.00335	CbGeAlD
Amitriptyline—HTR2A—renal system—urinary bladder cancer	0.000517	0.00323	CbGeAlD
Amitriptyline—CYP2C8—vagina—urinary bladder cancer	0.000512	0.00319	CbGeAlD
Amitriptyline—CYP2B6—female reproductive system—urinary bladder cancer	0.000507	0.00317	CbGeAlD
Amitriptyline—CYP2C9—female reproductive system—urinary bladder cancer	0.000502	0.00314	CbGeAlD
Amitriptyline—ABCB1—prostate gland—urinary bladder cancer	0.000497	0.0031	CbGeAlD
Amitriptyline—HRH1—female reproductive system—urinary bladder cancer	0.000496	0.00309	CbGeAlD
Amitriptyline—ADRA2A—female reproductive system—urinary bladder cancer	0.000487	0.00304	CbGeAlD
Amitriptyline—CYP3A4—renal system—urinary bladder cancer	0.000478	0.00299	CbGeAlD
Amitriptyline—CYP2E1—female reproductive system—urinary bladder cancer	0.000476	0.00297	CbGeAlD
Amitriptyline—ALB—lymph node—urinary bladder cancer	0.000471	0.00294	CbGeAlD
Amitriptyline—CYP2D6—renal system—urinary bladder cancer	0.000471	0.00294	CbGeAlD
Amitriptyline—CYP3A5—vagina—urinary bladder cancer	0.000462	0.00288	CbGeAlD
Amitriptyline—CYP2B6—vagina—urinary bladder cancer	0.000459	0.00287	CbGeAlD
Amitriptyline—SIGMAR1—lymph node—urinary bladder cancer	0.000454	0.00284	CbGeAlD
Amitriptyline—HRH1—vagina—urinary bladder cancer	0.000448	0.0028	CbGeAlD
Amitriptyline—ADRA2A—vagina—urinary bladder cancer	0.00044	0.00275	CbGeAlD
Amitriptyline—ABCB1—seminal vesicle—urinary bladder cancer	0.00042	0.00262	CbGeAlD
Amitriptyline—HTR2A—female reproductive system—urinary bladder cancer	0.000414	0.00258	CbGeAlD
Amitriptyline—SLC6A2—lymph node—urinary bladder cancer	0.000403	0.00252	CbGeAlD
Amitriptyline—CYP3A4—female reproductive system—urinary bladder cancer	0.000383	0.00239	CbGeAlD
Amitriptyline—CYP2D6—female reproductive system—urinary bladder cancer	0.000377	0.00235	CbGeAlD
Amitriptyline—HTR2A—vagina—urinary bladder cancer	0.000374	0.00234	CbGeAlD
Amitriptyline—ABCB1—epithelium—urinary bladder cancer	0.000365	0.00228	CbGeAlD
Amitriptyline—Discomfort—Cisplatin—urinary bladder cancer	0.000343	0.00173	CcSEcCtD
Amitriptyline—Tachycardia—Fluorouracil—urinary bladder cancer	0.000342	0.00173	CcSEcCtD
Amitriptyline—Anorexia—Gemcitabine—urinary bladder cancer	0.00034	0.00172	CcSEcCtD
Amitriptyline—ABCB1—renal system—urinary bladder cancer	0.000339	0.00211	CbGeAlD
Amitriptyline—Urticaria—Thiotepa—urinary bladder cancer	0.000337	0.0017	CcSEcCtD
Amitriptyline—Malaise—Etoposide—urinary bladder cancer	0.000336	0.0017	CcSEcCtD
Amitriptyline—Body temperature increased—Thiotepa—urinary bladder cancer	0.000335	0.0017	CcSEcCtD
Amitriptyline—Anorexia—Fluorouracil—urinary bladder cancer	0.000334	0.00169	CcSEcCtD
Amitriptyline—Leukopenia—Etoposide—urinary bladder cancer	0.000334	0.00169	CcSEcCtD
Amitriptyline—Purpura—Doxorubicin—urinary bladder cancer	0.000333	0.00169	CcSEcCtD
Amitriptyline—Hypotension—Gemcitabine—urinary bladder cancer	0.000333	0.00169	CcSEcCtD
Amitriptyline—ABCB1—urethra—urinary bladder cancer	0.000333	0.00208	CbGeAlD
Amitriptyline—Oedema—Cisplatin—urinary bladder cancer	0.000332	0.00168	CcSEcCtD
Amitriptyline—Loss of consciousness—Etoposide—urinary bladder cancer	0.000328	0.00166	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	0.000328	0.00166	CcSEcCtD
Amitriptyline—Hypotension—Fluorouracil—urinary bladder cancer	0.000328	0.00166	CcSEcCtD
Amitriptyline—Ataxia—Epirubicin—urinary bladder cancer	0.000327	0.00165	CcSEcCtD
Amitriptyline—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000325	0.00165	CcSEcCtD
Amitriptyline—Tachycardia—Cisplatin—urinary bladder cancer	0.000324	0.00164	CcSEcCtD
Amitriptyline—Convulsion—Etoposide—urinary bladder cancer	0.000323	0.00164	CcSEcCtD
Amitriptyline—Insomnia—Gemcitabine—urinary bladder cancer	0.000323	0.00163	CcSEcCtD
Amitriptyline—Hypertension—Etoposide—urinary bladder cancer	0.000322	0.00163	CcSEcCtD
Amitriptyline—Osteoarthritis—Doxorubicin—urinary bladder cancer	0.000321	0.00163	CcSEcCtD
Amitriptyline—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000321	0.00163	CcSEcCtD
Amitriptyline—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00032	0.00162	CcSEcCtD
Amitriptyline—Eosinophilia—Methotrexate—urinary bladder cancer	0.000318	0.00161	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.000317	0.0016	CcSEcCtD
Amitriptyline—Insomnia—Fluorouracil—urinary bladder cancer	0.000317	0.0016	CcSEcCtD
Amitriptyline—Somnolence—Gemcitabine—urinary bladder cancer	0.000317	0.0016	CcSEcCtD
Amitriptyline—Anorexia—Cisplatin—urinary bladder cancer	0.000317	0.0016	CcSEcCtD
Amitriptyline—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000315	0.00159	CcSEcCtD
Amitriptyline—Discomfort—Etoposide—urinary bladder cancer	0.000314	0.00159	CcSEcCtD
Amitriptyline—Somnolence—Fluorouracil—urinary bladder cancer	0.000312	0.00158	CcSEcCtD
Amitriptyline—Hypotension—Cisplatin—urinary bladder cancer	0.000311	0.00157	CcSEcCtD
Amitriptyline—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00031	0.00157	CcSEcCtD
Amitriptyline—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000309	0.00156	CcSEcCtD
Amitriptyline—Fatigue—Gemcitabine—urinary bladder cancer	0.000307	0.00156	CcSEcCtD
Amitriptyline—Confusional state—Etoposide—urinary bladder cancer	0.000307	0.00155	CcSEcCtD
Amitriptyline—Constipation—Gemcitabine—urinary bladder cancer	0.000305	0.00154	CcSEcCtD
Amitriptyline—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000305	0.00154	CcSEcCtD
Amitriptyline—Pancytopenia—Methotrexate—urinary bladder cancer	0.000305	0.00154	CcSEcCtD
Amitriptyline—Asthenia—Thiotepa—urinary bladder cancer	0.000304	0.00154	CcSEcCtD
Amitriptyline—Ataxia—Doxorubicin—urinary bladder cancer	0.000302	0.00153	CcSEcCtD
Amitriptyline—Pruritus—Thiotepa—urinary bladder cancer	0.0003	0.00152	CcSEcCtD
Amitriptyline—Paraesthesia—Cisplatin—urinary bladder cancer	0.000298	0.00151	CcSEcCtD
Amitriptyline—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000298	0.00151	CcSEcCtD
Amitriptyline—Tachycardia—Etoposide—urinary bladder cancer	0.000297	0.0015	CcSEcCtD
Amitriptyline—Eosinophilia—Epirubicin—urinary bladder cancer	0.000297	0.0015	CcSEcCtD
Amitriptyline—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000295	0.00149	CcSEcCtD
Amitriptyline—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000294	0.00149	CcSEcCtD
Amitriptyline—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000294	0.00149	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.000294	0.00148	CcSEcCtD
Amitriptyline—Anorexia—Etoposide—urinary bladder cancer	0.00029	0.00147	CcSEcCtD
Amitriptyline—Diarrhoea—Thiotepa—urinary bladder cancer	0.00029	0.00147	CcSEcCtD
Amitriptyline—HRH1—lymph node—urinary bladder cancer	0.00029	0.00181	CbGeAlD
Amitriptyline—Decreased appetite—Cisplatin—urinary bladder cancer	0.000289	0.00146	CcSEcCtD
Amitriptyline—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000289	0.00146	CcSEcCtD
Amitriptyline—Drowsiness—Methotrexate—urinary bladder cancer	0.000286	0.00145	CcSEcCtD
Amitriptyline—Pancytopenia—Epirubicin—urinary bladder cancer	0.000285	0.00144	CcSEcCtD
Amitriptyline—ADRA2A—lymph node—urinary bladder cancer	0.000285	0.00178	CbGeAlD
Amitriptyline—Hypotension—Etoposide—urinary bladder cancer	0.000285	0.00144	CcSEcCtD
Amitriptyline—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000282	0.00143	CcSEcCtD
Amitriptyline—Dizziness—Thiotepa—urinary bladder cancer	0.00028	0.00142	CcSEcCtD
Amitriptyline—Stomatitis—Methotrexate—urinary bladder cancer	0.000279	0.00141	CcSEcCtD
Amitriptyline—Urticaria—Fluorouracil—urinary bladder cancer	0.000279	0.00141	CcSEcCtD
Amitriptyline—Pollakiuria—Epirubicin—urinary bladder cancer	0.000277	0.0014	CcSEcCtD
Amitriptyline—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000277	0.0014	CcSEcCtD
Amitriptyline—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000275	0.00139	CcSEcCtD
Amitriptyline—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000274	0.00139	CcSEcCtD
Amitriptyline—Paraesthesia—Etoposide—urinary bladder cancer	0.000273	0.00138	CcSEcCtD
Amitriptyline—Weight increased—Epirubicin—urinary bladder cancer	0.000273	0.00138	CcSEcCtD
Amitriptyline—ABCB1—female reproductive system—urinary bladder cancer	0.000271	0.00169	CbGeAlD
Amitriptyline—Somnolence—Etoposide—urinary bladder cancer	0.000271	0.00137	CcSEcCtD
Amitriptyline—Vomiting—Thiotepa—urinary bladder cancer	0.00027	0.00136	CcSEcCtD
Amitriptyline—Drowsiness—Epirubicin—urinary bladder cancer	0.000268	0.00135	CcSEcCtD
Amitriptyline—Rash—Thiotepa—urinary bladder cancer	0.000267	0.00135	CcSEcCtD
Amitriptyline—Dermatitis—Thiotepa—urinary bladder cancer	0.000267	0.00135	CcSEcCtD
Amitriptyline—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000267	0.00135	CcSEcCtD
Amitriptyline—Headache—Thiotepa—urinary bladder cancer	0.000266	0.00134	CcSEcCtD
Amitriptyline—Decreased appetite—Etoposide—urinary bladder cancer	0.000265	0.00134	CcSEcCtD
Amitriptyline—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000264	0.00133	CcSEcCtD
Amitriptyline—Body temperature increased—Cisplatin—urinary bladder cancer	0.000263	0.00133	CcSEcCtD
Amitriptyline—Fatigue—Etoposide—urinary bladder cancer	0.000263	0.00133	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000262	0.00133	CcSEcCtD
Amitriptyline—Jaundice—Epirubicin—urinary bladder cancer	0.000261	0.00132	CcSEcCtD
Amitriptyline—Stomatitis—Epirubicin—urinary bladder cancer	0.000261	0.00132	CcSEcCtD
Amitriptyline—Constipation—Etoposide—urinary bladder cancer	0.00026	0.00132	CcSEcCtD
Amitriptyline—Hepatitis—Methotrexate—urinary bladder cancer	0.000257	0.0013	CcSEcCtD
Amitriptyline—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000257	0.0013	CcSEcCtD
Amitriptyline—Asthenia—Gemcitabine—urinary bladder cancer	0.000256	0.00129	CcSEcCtD
Amitriptyline—Weight increased—Doxorubicin—urinary bladder cancer	0.000253	0.00128	CcSEcCtD
Amitriptyline—Pruritus—Gemcitabine—urinary bladder cancer	0.000252	0.00128	CcSEcCtD
Amitriptyline—Nausea—Thiotepa—urinary bladder cancer	0.000252	0.00127	CcSEcCtD
Amitriptyline—Feeling abnormal—Etoposide—urinary bladder cancer	0.000251	0.00127	CcSEcCtD
Amitriptyline—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00025	0.00126	CcSEcCtD
Amitriptyline—Pruritus—Fluorouracil—urinary bladder cancer	0.000248	0.00126	CcSEcCtD
Amitriptyline—Drowsiness—Doxorubicin—urinary bladder cancer	0.000248	0.00125	CcSEcCtD
Amitriptyline—ABCB1—vagina—urinary bladder cancer	0.000245	0.00153	CbGeAlD
Amitriptyline—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000244	0.00123	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000243	0.00123	CcSEcCtD
Amitriptyline—Urticaria—Etoposide—urinary bladder cancer	0.000242	0.00122	CcSEcCtD
Amitriptyline—Stomatitis—Doxorubicin—urinary bladder cancer	0.000241	0.00122	CcSEcCtD
Amitriptyline—Jaundice—Doxorubicin—urinary bladder cancer	0.000241	0.00122	CcSEcCtD
Amitriptyline—Body temperature increased—Etoposide—urinary bladder cancer	0.000241	0.00122	CcSEcCtD
Amitriptyline—Hepatitis—Epirubicin—urinary bladder cancer	0.00024	0.00122	CcSEcCtD
Amitriptyline—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00024	0.00121	CcSEcCtD
Amitriptyline—Tinnitus—Methotrexate—urinary bladder cancer	0.000239	0.00121	CcSEcCtD
Amitriptyline—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000239	0.00121	CcSEcCtD
Amitriptyline—Asthenia—Cisplatin—urinary bladder cancer	0.000238	0.00121	CcSEcCtD
Amitriptyline—Dizziness—Fluorouracil—urinary bladder cancer	0.000232	0.00117	CcSEcCtD
Amitriptyline—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000231	0.00117	CcSEcCtD
Amitriptyline—Diarrhoea—Cisplatin—urinary bladder cancer	0.000227	0.00115	CcSEcCtD
Amitriptyline—Alopecia—Methotrexate—urinary bladder cancer	0.000227	0.00115	CcSEcCtD
Amitriptyline—Vomiting—Gemcitabine—urinary bladder cancer	0.000227	0.00115	CcSEcCtD
Amitriptyline—Rash—Gemcitabine—urinary bladder cancer	0.000225	0.00114	CcSEcCtD
Amitriptyline—Dermatitis—Gemcitabine—urinary bladder cancer	0.000225	0.00114	CcSEcCtD
Amitriptyline—Tinnitus—Epirubicin—urinary bladder cancer	0.000224	0.00113	CcSEcCtD
Amitriptyline—Headache—Gemcitabine—urinary bladder cancer	0.000223	0.00113	CcSEcCtD
Amitriptyline—Vomiting—Fluorouracil—urinary bladder cancer	0.000223	0.00113	CcSEcCtD
Amitriptyline—Hepatitis—Doxorubicin—urinary bladder cancer	0.000222	0.00112	CcSEcCtD
Amitriptyline—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000221	0.00112	CcSEcCtD
Amitriptyline—Rash—Fluorouracil—urinary bladder cancer	0.000221	0.00112	CcSEcCtD
Amitriptyline—Dermatitis—Fluorouracil—urinary bladder cancer	0.000221	0.00112	CcSEcCtD
Amitriptyline—Headache—Fluorouracil—urinary bladder cancer	0.00022	0.00111	CcSEcCtD
Amitriptyline—Dysgeusia—Methotrexate—urinary bladder cancer	0.000219	0.00111	CcSEcCtD
Amitriptyline—Asthenia—Etoposide—urinary bladder cancer	0.000218	0.00111	CcSEcCtD
Amitriptyline—Pruritus—Etoposide—urinary bladder cancer	0.000215	0.00109	CcSEcCtD
Amitriptyline—Arrhythmia—Epirubicin—urinary bladder cancer	0.000215	0.00109	CcSEcCtD
Amitriptyline—Alopecia—Epirubicin—urinary bladder cancer	0.000212	0.00107	CcSEcCtD
Amitriptyline—Nausea—Gemcitabine—urinary bladder cancer	0.000212	0.00107	CcSEcCtD
Amitriptyline—Vomiting—Cisplatin—urinary bladder cancer	0.000211	0.00107	CcSEcCtD
Amitriptyline—Vision blurred—Methotrexate—urinary bladder cancer	0.000211	0.00107	CcSEcCtD
Amitriptyline—Rash—Cisplatin—urinary bladder cancer	0.00021	0.00106	CcSEcCtD
Amitriptyline—Dermatitis—Cisplatin—urinary bladder cancer	0.000209	0.00106	CcSEcCtD
Amitriptyline—Diarrhoea—Etoposide—urinary bladder cancer	0.000208	0.00105	CcSEcCtD
Amitriptyline—Nausea—Fluorouracil—urinary bladder cancer	0.000208	0.00105	CcSEcCtD
Amitriptyline—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000207	0.00105	CcSEcCtD
Amitriptyline—Tinnitus—Doxorubicin—urinary bladder cancer	0.000207	0.00105	CcSEcCtD
Amitriptyline—Dysgeusia—Epirubicin—urinary bladder cancer	0.000205	0.00104	CcSEcCtD
Amitriptyline—Malaise—Methotrexate—urinary bladder cancer	0.000202	0.00102	CcSEcCtD
Amitriptyline—Dizziness—Etoposide—urinary bladder cancer	0.000201	0.00102	CcSEcCtD
Amitriptyline—Leukopenia—Methotrexate—urinary bladder cancer	0.0002	0.00101	CcSEcCtD
Amitriptyline—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000199	0.001	CcSEcCtD
Amitriptyline—Nausea—Cisplatin—urinary bladder cancer	0.000197	0.000999	CcSEcCtD
Amitriptyline—Vision blurred—Epirubicin—urinary bladder cancer	0.000197	0.000997	CcSEcCtD
Amitriptyline—Alopecia—Doxorubicin—urinary bladder cancer	0.000196	0.000994	CcSEcCtD
Amitriptyline—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000194	0.000982	CcSEcCtD
Amitriptyline—Convulsion—Methotrexate—urinary bladder cancer	0.000194	0.00098	CcSEcCtD
Amitriptyline—Vomiting—Etoposide—urinary bladder cancer	0.000194	0.00098	CcSEcCtD
Amitriptyline—Agitation—Epirubicin—urinary bladder cancer	0.000192	0.000972	CcSEcCtD
Amitriptyline—Rash—Etoposide—urinary bladder cancer	0.000192	0.000971	CcSEcCtD
Amitriptyline—Dermatitis—Etoposide—urinary bladder cancer	0.000192	0.00097	CcSEcCtD
Amitriptyline—Headache—Etoposide—urinary bladder cancer	0.000191	0.000965	CcSEcCtD
Amitriptyline—Dysgeusia—Doxorubicin—urinary bladder cancer	0.00019	0.000959	CcSEcCtD
Amitriptyline—Malaise—Epirubicin—urinary bladder cancer	0.000189	0.000954	CcSEcCtD
Amitriptyline—Discomfort—Methotrexate—urinary bladder cancer	0.000188	0.000951	CcSEcCtD
Amitriptyline—Syncope—Epirubicin—urinary bladder cancer	0.000188	0.000949	CcSEcCtD
Amitriptyline—Leukopenia—Epirubicin—urinary bladder cancer	0.000187	0.000947	CcSEcCtD
Amitriptyline—Palpitations—Epirubicin—urinary bladder cancer	0.000185	0.000935	CcSEcCtD
Amitriptyline—Confusional state—Methotrexate—urinary bladder cancer	0.000184	0.00093	CcSEcCtD
Amitriptyline—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000184	0.00093	CcSEcCtD
Amitriptyline—Vision blurred—Doxorubicin—urinary bladder cancer	0.000182	0.000923	CcSEcCtD
Amitriptyline—Convulsion—Epirubicin—urinary bladder cancer	0.000181	0.000917	CcSEcCtD
Amitriptyline—Nausea—Etoposide—urinary bladder cancer	0.000181	0.000915	CcSEcCtD
Amitriptyline—Hypertension—Epirubicin—urinary bladder cancer	0.000181	0.000914	CcSEcCtD
Amitriptyline—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00018	0.000908	CcSEcCtD
Amitriptyline—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000179	0.000904	CcSEcCtD
Amitriptyline—Agitation—Doxorubicin—urinary bladder cancer	0.000178	0.0009	CcSEcCtD
Amitriptyline—Anxiety—Epirubicin—urinary bladder cancer	0.000177	0.000898	CcSEcCtD
Amitriptyline—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000176	0.000892	CcSEcCtD
Amitriptyline—Discomfort—Epirubicin—urinary bladder cancer	0.000176	0.00089	CcSEcCtD
Amitriptyline—Malaise—Doxorubicin—urinary bladder cancer	0.000175	0.000883	CcSEcCtD
Amitriptyline—Dry mouth—Epirubicin—urinary bladder cancer	0.000174	0.000881	CcSEcCtD
Amitriptyline—Anorexia—Methotrexate—urinary bladder cancer	0.000174	0.00088	CcSEcCtD
Amitriptyline—Syncope—Doxorubicin—urinary bladder cancer	0.000174	0.000878	CcSEcCtD
Amitriptyline—Leukopenia—Doxorubicin—urinary bladder cancer	0.000173	0.000876	CcSEcCtD
Amitriptyline—Confusional state—Epirubicin—urinary bladder cancer	0.000172	0.000871	CcSEcCtD
Amitriptyline—Palpitations—Doxorubicin—urinary bladder cancer	0.000171	0.000865	CcSEcCtD
Amitriptyline—Oedema—Epirubicin—urinary bladder cancer	0.000171	0.000864	CcSEcCtD
Amitriptyline—Hypotension—Methotrexate—urinary bladder cancer	0.00017	0.000862	CcSEcCtD
Amitriptyline—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00017	0.000861	CcSEcCtD
Amitriptyline—Shock—Epirubicin—urinary bladder cancer	0.000168	0.00085	CcSEcCtD
Amitriptyline—Convulsion—Doxorubicin—urinary bladder cancer	0.000168	0.000848	CcSEcCtD
Amitriptyline—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000167	0.000846	CcSEcCtD
Amitriptyline—Hypertension—Doxorubicin—urinary bladder cancer	0.000167	0.000845	CcSEcCtD
Amitriptyline—Tachycardia—Epirubicin—urinary bladder cancer	0.000167	0.000843	CcSEcCtD
Amitriptyline—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000165	0.000835	CcSEcCtD
Amitriptyline—Insomnia—Methotrexate—urinary bladder cancer	0.000165	0.000835	CcSEcCtD
Amitriptyline—Anxiety—Doxorubicin—urinary bladder cancer	0.000164	0.000831	CcSEcCtD
Amitriptyline—Paraesthesia—Methotrexate—urinary bladder cancer	0.000164	0.000829	CcSEcCtD
Amitriptyline—Discomfort—Doxorubicin—urinary bladder cancer	0.000163	0.000824	CcSEcCtD
Amitriptyline—Anorexia—Epirubicin—urinary bladder cancer	0.000163	0.000823	CcSEcCtD
Amitriptyline—Somnolence—Methotrexate—urinary bladder cancer	0.000162	0.00082	CcSEcCtD
Amitriptyline—Dry mouth—Doxorubicin—urinary bladder cancer	0.000161	0.000815	CcSEcCtD
Amitriptyline—Dyspepsia—Methotrexate—urinary bladder cancer	0.000161	0.000812	CcSEcCtD
Amitriptyline—Hypotension—Epirubicin—urinary bladder cancer	0.00016	0.000807	CcSEcCtD
Amitriptyline—Confusional state—Doxorubicin—urinary bladder cancer	0.000159	0.000806	CcSEcCtD
Amitriptyline—ABCB1—lymph node—urinary bladder cancer	0.000159	0.000991	CbGeAlD
Amitriptyline—Decreased appetite—Methotrexate—urinary bladder cancer	0.000159	0.000802	CcSEcCtD
Amitriptyline—Oedema—Doxorubicin—urinary bladder cancer	0.000158	0.000799	CcSEcCtD
Amitriptyline—Fatigue—Methotrexate—urinary bladder cancer	0.000157	0.000796	CcSEcCtD
Amitriptyline—Shock—Doxorubicin—urinary bladder cancer	0.000155	0.000786	CcSEcCtD
Amitriptyline—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000155	0.000782	CcSEcCtD
Amitriptyline—Insomnia—Epirubicin—urinary bladder cancer	0.000154	0.000781	CcSEcCtD
Amitriptyline—Tachycardia—Doxorubicin—urinary bladder cancer	0.000154	0.00078	CcSEcCtD
Amitriptyline—Paraesthesia—Epirubicin—urinary bladder cancer	0.000153	0.000775	CcSEcCtD
Amitriptyline—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000153	0.000772	CcSEcCtD
Amitriptyline—Somnolence—Epirubicin—urinary bladder cancer	0.000152	0.000768	CcSEcCtD
Amitriptyline—Anorexia—Doxorubicin—urinary bladder cancer	0.000151	0.000762	CcSEcCtD
Amitriptyline—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00015	0.00076	CcSEcCtD
Amitriptyline—Dyspepsia—Epirubicin—urinary bladder cancer	0.00015	0.00076	CcSEcCtD
Amitriptyline—Decreased appetite—Epirubicin—urinary bladder cancer	0.000148	0.000751	CcSEcCtD
Amitriptyline—Hypotension—Doxorubicin—urinary bladder cancer	0.000148	0.000747	CcSEcCtD
Amitriptyline—Fatigue—Epirubicin—urinary bladder cancer	0.000147	0.000745	CcSEcCtD
Amitriptyline—Constipation—Epirubicin—urinary bladder cancer	0.000146	0.000738	CcSEcCtD
Amitriptyline—Urticaria—Methotrexate—urinary bladder cancer	0.000145	0.000733	CcSEcCtD
Amitriptyline—Body temperature increased—Methotrexate—urinary bladder cancer	0.000144	0.000729	CcSEcCtD
Amitriptyline—Insomnia—Doxorubicin—urinary bladder cancer	0.000143	0.000723	CcSEcCtD
Amitriptyline—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000142	0.000718	CcSEcCtD
Amitriptyline—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000141	0.000712	CcSEcCtD
Amitriptyline—Somnolence—Doxorubicin—urinary bladder cancer	0.00014	0.00071	CcSEcCtD
Amitriptyline—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000139	0.000703	CcSEcCtD
Amitriptyline—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000137	0.000695	CcSEcCtD
Amitriptyline—Fatigue—Doxorubicin—urinary bladder cancer	0.000136	0.000689	CcSEcCtD
Amitriptyline—Urticaria—Epirubicin—urinary bladder cancer	0.000136	0.000686	CcSEcCtD
Amitriptyline—Constipation—Doxorubicin—urinary bladder cancer	0.000135	0.000683	CcSEcCtD
Amitriptyline—Body temperature increased—Epirubicin—urinary bladder cancer	0.000135	0.000683	CcSEcCtD
Amitriptyline—Asthenia—Methotrexate—urinary bladder cancer	0.000131	0.000662	CcSEcCtD
Amitriptyline—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00013	0.000658	CcSEcCtD
Amitriptyline—Pruritus—Methotrexate—urinary bladder cancer	0.000129	0.000653	CcSEcCtD
Amitriptyline—Urticaria—Doxorubicin—urinary bladder cancer	0.000125	0.000635	CcSEcCtD
Amitriptyline—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000125	0.000632	CcSEcCtD
Amitriptyline—Diarrhoea—Methotrexate—urinary bladder cancer	0.000125	0.000631	CcSEcCtD
Amitriptyline—Asthenia—Epirubicin—urinary bladder cancer	0.000122	0.00062	CcSEcCtD
Amitriptyline—Pruritus—Epirubicin—urinary bladder cancer	0.000121	0.000611	CcSEcCtD
Amitriptyline—Dizziness—Methotrexate—urinary bladder cancer	0.000121	0.00061	CcSEcCtD
Amitriptyline—Diarrhoea—Epirubicin—urinary bladder cancer	0.000117	0.000591	CcSEcCtD
Amitriptyline—Vomiting—Methotrexate—urinary bladder cancer	0.000116	0.000587	CcSEcCtD
Amitriptyline—Rash—Methotrexate—urinary bladder cancer	0.000115	0.000582	CcSEcCtD
Amitriptyline—Dermatitis—Methotrexate—urinary bladder cancer	0.000115	0.000581	CcSEcCtD
Amitriptyline—Headache—Methotrexate—urinary bladder cancer	0.000114	0.000578	CcSEcCtD
Amitriptyline—Asthenia—Doxorubicin—urinary bladder cancer	0.000113	0.000573	CcSEcCtD
Amitriptyline—Dizziness—Epirubicin—urinary bladder cancer	0.000113	0.000571	CcSEcCtD
Amitriptyline—Pruritus—Doxorubicin—urinary bladder cancer	0.000112	0.000565	CcSEcCtD
Amitriptyline—Vomiting—Epirubicin—urinary bladder cancer	0.000109	0.000549	CcSEcCtD
Amitriptyline—Nausea—Methotrexate—urinary bladder cancer	0.000108	0.000548	CcSEcCtD
Amitriptyline—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000108	0.000547	CcSEcCtD
Amitriptyline—Rash—Epirubicin—urinary bladder cancer	0.000108	0.000545	CcSEcCtD
Amitriptyline—Dermatitis—Epirubicin—urinary bladder cancer	0.000108	0.000544	CcSEcCtD
Amitriptyline—Headache—Epirubicin—urinary bladder cancer	0.000107	0.000541	CcSEcCtD
Amitriptyline—Dizziness—Doxorubicin—urinary bladder cancer	0.000104	0.000528	CcSEcCtD
Amitriptyline—Nausea—Epirubicin—urinary bladder cancer	0.000101	0.000513	CcSEcCtD
Amitriptyline—Vomiting—Doxorubicin—urinary bladder cancer	0.0001	0.000508	CcSEcCtD
Amitriptyline—Rash—Doxorubicin—urinary bladder cancer	9.96e-05	0.000504	CcSEcCtD
Amitriptyline—Dermatitis—Doxorubicin—urinary bladder cancer	9.95e-05	0.000503	CcSEcCtD
Amitriptyline—Headache—Doxorubicin—urinary bladder cancer	9.89e-05	0.000501	CcSEcCtD
Amitriptyline—Nausea—Doxorubicin—urinary bladder cancer	9.38e-05	0.000475	CcSEcCtD
Amitriptyline—HTR2C—Signaling Pathways—CCND1—urinary bladder cancer	6e-06	4.13e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—ERBB2—urinary bladder cancer	5.99e-06	4.13e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—KRAS—urinary bladder cancer	5.99e-06	4.13e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—PTEN—urinary bladder cancer	5.96e-06	4.11e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—KRAS—urinary bladder cancer	5.94e-06	4.1e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—HRAS—urinary bladder cancer	5.94e-06	4.09e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—MYC—urinary bladder cancer	5.9e-06	4.07e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—ERBB2—urinary bladder cancer	5.89e-06	4.06e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IL2—urinary bladder cancer	5.89e-06	4.06e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—ERBB2—urinary bladder cancer	5.88e-06	4.05e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—GPX1—urinary bladder cancer	5.88e-06	4.05e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	5.88e-06	4.05e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—KRAS—urinary bladder cancer	5.86e-06	4.04e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—ERBB2—urinary bladder cancer	5.86e-06	4.04e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MMP9—urinary bladder cancer	5.85e-06	4.03e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—ERBB2—urinary bladder cancer	5.84e-06	4.03e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CDKN1A—urinary bladder cancer	5.83e-06	4.02e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MMP9—urinary bladder cancer	5.82e-06	4.01e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—PTEN—urinary bladder cancer	5.82e-06	4.01e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CDKN1A—urinary bladder cancer	5.8e-06	4e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—RHOA—urinary bladder cancer	5.79e-06	3.99e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—PTEN—urinary bladder cancer	5.79e-06	3.99e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—ERBB2—urinary bladder cancer	5.79e-06	3.99e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	5.77e-06	3.98e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—EGFR—urinary bladder cancer	5.77e-06	3.98e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—ERBB2—urinary bladder cancer	5.77e-06	3.98e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	5.76e-06	3.97e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	5.75e-06	3.96e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CCND1—urinary bladder cancer	5.74e-06	3.96e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—KRAS—urinary bladder cancer	5.69e-06	3.92e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—EP300—urinary bladder cancer	5.68e-06	3.92e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CXCL8—urinary bladder cancer	5.68e-06	3.91e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PPARG—urinary bladder cancer	5.65e-06	3.89e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—HRAS—urinary bladder cancer	5.64e-06	3.89e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—MYC—urinary bladder cancer	5.6e-06	3.86e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CXCL8—urinary bladder cancer	5.59e-06	3.85e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CXCL8—urinary bladder cancer	5.58e-06	3.84e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MMP9—urinary bladder cancer	5.57e-06	3.84e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CXCL8—urinary bladder cancer	5.56e-06	3.83e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—HRAS—urinary bladder cancer	5.55e-06	3.83e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CDKN1A—urinary bladder cancer	5.55e-06	3.83e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—EP300—urinary bladder cancer	5.55e-06	3.82e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—MYC—urinary bladder cancer	5.55e-06	3.82e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—MYC—urinary bladder cancer	5.55e-06	3.82e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CXCL8—urinary bladder cancer	5.54e-06	3.82e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—HRAS—urinary bladder cancer	5.54e-06	3.82e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—PTEN—urinary bladder cancer	5.54e-06	3.82e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—HRAS—urinary bladder cancer	5.52e-06	3.81e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—EP300—urinary bladder cancer	5.52e-06	3.8e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PPARG—urinary bladder cancer	5.51e-06	3.8e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—HRAS—urinary bladder cancer	5.51e-06	3.79e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CXCL8—urinary bladder cancer	5.49e-06	3.78e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—EGFR—urinary bladder cancer	5.48e-06	3.78e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CXCL8—urinary bladder cancer	5.47e-06	3.77e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PTEN—urinary bladder cancer	5.47e-06	3.77e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—HRAS—urinary bladder cancer	5.45e-06	3.76e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—KRAS—urinary bladder cancer	5.45e-06	3.76e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—TP53—urinary bladder cancer	5.44e-06	3.75e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—HRAS—urinary bladder cancer	5.44e-06	3.75e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IL2—urinary bladder cancer	5.43e-06	3.74e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	5.43e-06	3.74e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—EGFR—urinary bladder cancer	5.43e-06	3.74e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—EGFR—urinary bladder cancer	5.43e-06	3.74e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	5.42e-06	3.74e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—SRC—urinary bladder cancer	5.39e-06	3.72e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—SRC—urinary bladder cancer	5.37e-06	3.7e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—TP53—urinary bladder cancer	5.36e-06	3.7e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—ERBB2—urinary bladder cancer	5.36e-06	3.69e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—TP53—urinary bladder cancer	5.36e-06	3.69e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IL2—urinary bladder cancer	5.34e-06	3.68e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IL2—urinary bladder cancer	5.33e-06	3.67e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—TP53—urinary bladder cancer	5.32e-06	3.67e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IL2—urinary bladder cancer	5.31e-06	3.66e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IL2—urinary bladder cancer	5.3e-06	3.65e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—CREBBP—urinary bladder cancer	5.29e-06	3.65e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CCND1—urinary bladder cancer	5.29e-06	3.65e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—EP300—urinary bladder cancer	5.28e-06	3.64e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IL2—urinary bladder cancer	5.24e-06	3.61e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IL2—urinary bladder cancer	5.23e-06	3.6e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—EP300—urinary bladder cancer	5.21e-06	3.59e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—TP53—urinary bladder cancer	5.21e-06	3.59e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CCND1—urinary bladder cancer	5.21e-06	3.59e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—HRAS—urinary bladder cancer	5.2e-06	3.59e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CCND1—urinary bladder cancer	5.2e-06	3.58e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PPARG—urinary bladder cancer	5.19e-06	3.58e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CCND1—urinary bladder cancer	5.18e-06	3.57e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—KRAS—urinary bladder cancer	5.17e-06	3.57e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CCND1—urinary bladder cancer	5.16e-06	3.56e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	5.16e-06	3.55e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PPARG—urinary bladder cancer	5.15e-06	3.55e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—SRC—urinary bladder cancer	5.14e-06	3.54e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MMP9—urinary bladder cancer	5.14e-06	3.54e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—HRAS—urinary bladder cancer	5.13e-06	3.53e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PTEN—urinary bladder cancer	5.13e-06	3.53e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—KRAS—urinary bladder cancer	5.13e-06	3.53e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—KRAS—urinary bladder cancer	5.13e-06	3.53e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—HRAS—urinary bladder cancer	5.12e-06	3.53e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CDKN1A—urinary bladder cancer	5.12e-06	3.53e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CCND1—urinary bladder cancer	5.11e-06	3.52e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—PTEN—urinary bladder cancer	5.11e-06	3.52e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CCND1—urinary bladder cancer	5.1e-06	3.51e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—HRAS—urinary bladder cancer	5.09e-06	3.51e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CXCL8—urinary bladder cancer	5.08e-06	3.5e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—TP53—urinary bladder cancer	5.06e-06	3.49e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MMP9—urinary bladder cancer	5.05e-06	3.48e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—HRAS—urinary bladder cancer	5.05e-06	3.48e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MMP9—urinary bladder cancer	5.04e-06	3.48e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CDKN1A—urinary bladder cancer	5.04e-06	3.47e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MMP9—urinary bladder cancer	5.03e-06	3.46e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CDKN1A—urinary bladder cancer	5.03e-06	3.46e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—PTEN—urinary bladder cancer	5.03e-06	3.46e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PTEN—urinary bladder cancer	5.02e-06	3.46e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PTEN—urinary bladder cancer	5.01e-06	3.46e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MMP9—urinary bladder cancer	5.01e-06	3.45e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PTEN—urinary bladder cancer	5.01e-06	3.45e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CDKN1A—urinary bladder cancer	5.01e-06	3.45e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PTEN—urinary bladder cancer	5e-06	3.44e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CDKN1A—urinary bladder cancer	4.99e-06	3.44e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	4.99e-06	3.44e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—HRAS—urinary bladder cancer	4.98e-06	3.43e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PTEN—urinary bladder cancer	4.98e-06	3.43e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	4.98e-06	3.43e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MMP9—urinary bladder cancer	4.96e-06	3.42e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MMP9—urinary bladder cancer	4.95e-06	3.41e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTGS2—urinary bladder cancer	4.95e-06	3.41e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	4.95e-06	3.41e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CDKN1A—urinary bladder cancer	4.95e-06	3.41e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PTEN—urinary bladder cancer	4.93e-06	3.4e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CDKN1A—urinary bladder cancer	4.93e-06	3.4e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PTEN—urinary bladder cancer	4.92e-06	3.39e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—EP300—urinary bladder cancer	4.89e-06	3.37e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EP300—urinary bladder cancer	4.87e-06	3.36e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL2—urinary bladder cancer	4.86e-06	3.35e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TP53—urinary bladder cancer	4.84e-06	3.34e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—HRAS—urinary bladder cancer	4.84e-06	3.33e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MYC—urinary bladder cancer	4.83e-06	3.33e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MYC—urinary bladder cancer	4.81e-06	3.31e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—TYMS—urinary bladder cancer	4.79e-06	3.3e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EP300—urinary bladder cancer	4.79e-06	3.3e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—EP300—urinary bladder cancer	4.79e-06	3.3e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EP300—urinary bladder cancer	4.78e-06	3.3e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—EP300—urinary bladder cancer	4.78e-06	3.29e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EP300—urinary bladder cancer	4.77e-06	3.29e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EP300—urinary bladder cancer	4.75e-06	3.27e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	4.74e-06	3.27e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	4.74e-06	3.27e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CCND1—urinary bladder cancer	4.74e-06	3.26e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—SRC—urinary bladder cancer	4.74e-06	3.26e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—EGFR—urinary bladder cancer	4.73e-06	3.26e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EP300—urinary bladder cancer	4.71e-06	3.24e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—EGFR—urinary bladder cancer	4.7e-06	3.24e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EP300—urinary bladder cancer	4.69e-06	3.23e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—SRC—urinary bladder cancer	4.66e-06	3.21e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—SRC—urinary bladder cancer	4.65e-06	3.2e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—SRC—urinary bladder cancer	4.64e-06	3.19e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—HRAS—urinary bladder cancer	4.63e-06	3.19e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—SRC—urinary bladder cancer	4.62e-06	3.18e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MYC—urinary bladder cancer	4.6e-06	3.17e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TP53—urinary bladder cancer	4.6e-06	3.17e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MMP9—urinary bladder cancer	4.6e-06	3.17e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CDKN1A—urinary bladder cancer	4.58e-06	3.16e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—SRC—urinary bladder cancer	4.58e-06	3.15e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PTEN—urinary bladder cancer	4.57e-06	3.15e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—SRC—urinary bladder cancer	4.56e-06	3.14e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TP53—urinary bladder cancer	4.56e-06	3.14e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TP53—urinary bladder cancer	4.56e-06	3.14e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GPX1—urinary bladder cancer	4.54e-06	3.13e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—EGFR—urinary bladder cancer	4.5e-06	3.1e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—KRAS—urinary bladder cancer	4.47e-06	3.08e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	4.45e-06	3.07e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—KRAS—urinary bladder cancer	4.44e-06	3.06e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	4.44e-06	3.06e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PPARG—urinary bladder cancer	4.4e-06	3.03e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—HRAS—urinary bladder cancer	4.4e-06	3.03e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EP300—urinary bladder cancer	4.36e-06	3e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—HRAS—urinary bladder cancer	4.36e-06	3e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—HRAS—urinary bladder cancer	4.36e-06	3e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTEN—urinary bladder cancer	4.34e-06	2.99e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTGS2—urinary bladder cancer	4.34e-06	2.99e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTEN—urinary bladder cancer	4.32e-06	2.97e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—KRAS—urinary bladder cancer	4.25e-06	2.93e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MYC—urinary bladder cancer	4.24e-06	2.93e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—SRC—urinary bladder cancer	4.24e-06	2.92e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	4.23e-06	2.91e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	4.19e-06	2.89e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MYC—urinary bladder cancer	4.18e-06	2.88e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MYC—urinary bladder cancer	4.17e-06	2.87e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MYC—urinary bladder cancer	4.15e-06	2.86e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EGFR—urinary bladder cancer	4.15e-06	2.86e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MYC—urinary bladder cancer	4.14e-06	2.85e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—EP300—urinary bladder cancer	4.14e-06	2.85e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—EP300—urinary bladder cancer	4.12e-06	2.84e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MYC—urinary bladder cancer	4.1e-06	2.83e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MYC—urinary bladder cancer	4.09e-06	2.82e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	4.09e-06	2.82e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EGFR—urinary bladder cancer	4.08e-06	2.82e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EGFR—urinary bladder cancer	4.08e-06	2.81e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EGFR—urinary bladder cancer	4.06e-06	2.8e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	4.05e-06	2.79e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EGFR—urinary bladder cancer	4.05e-06	2.79e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EGFR—urinary bladder cancer	4.01e-06	2.76e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EGFR—urinary bladder cancer	4e-06	2.76e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TP53—urinary bladder cancer	3.97e-06	2.74e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TP53—urinary bladder cancer	3.95e-06	2.72e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—KRAS—urinary bladder cancer	3.92e-06	2.7e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTEN—urinary bladder cancer	3.87e-06	2.67e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—KRAS—urinary bladder cancer	3.86e-06	2.66e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—KRAS—urinary bladder cancer	3.85e-06	2.65e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—KRAS—urinary bladder cancer	3.84e-06	2.65e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—KRAS—urinary bladder cancer	3.83e-06	2.64e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MYC—urinary bladder cancer	3.8e-06	2.62e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—HRAS—urinary bladder cancer	3.8e-06	2.62e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—KRAS—urinary bladder cancer	3.79e-06	2.61e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTEN—urinary bladder cancer	3.78e-06	2.61e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TP53—urinary bladder cancer	3.78e-06	2.61e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—KRAS—urinary bladder cancer	3.78e-06	2.6e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—HRAS—urinary bladder cancer	3.78e-06	2.6e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EGFR—urinary bladder cancer	3.72e-06	2.56e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—EP300—urinary bladder cancer	3.69e-06	2.55e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—HRAS—urinary bladder cancer	3.62e-06	2.49e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—EP300—urinary bladder cancer	3.61e-06	2.48e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTEN—urinary bladder cancer	3.56e-06	2.46e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTEN—urinary bladder cancer	3.53e-06	2.43e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—KRAS—urinary bladder cancer	3.51e-06	2.42e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TP53—urinary bladder cancer	3.49e-06	2.4e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	3.46e-06	2.39e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TP53—urinary bladder cancer	3.43e-06	2.36e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TP53—urinary bladder cancer	3.42e-06	2.36e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TP53—urinary bladder cancer	3.41e-06	2.35e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TP53—urinary bladder cancer	3.4e-06	2.34e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—EP300—urinary bladder cancer	3.4e-06	2.34e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.4e-06	2.34e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—EP300—urinary bladder cancer	3.37e-06	2.32e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TP53—urinary bladder cancer	3.37e-06	2.32e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TP53—urinary bladder cancer	3.36e-06	2.31e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—HRAS—urinary bladder cancer	3.33e-06	2.3e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—HRAS—urinary bladder cancer	3.28e-06	2.26e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—HRAS—urinary bladder cancer	3.27e-06	2.26e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—HRAS—urinary bladder cancer	3.26e-06	2.25e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.26e-06	2.25e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—HRAS—urinary bladder cancer	3.25e-06	2.24e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—HRAS—urinary bladder cancer	3.22e-06	2.22e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—HRAS—urinary bladder cancer	3.21e-06	2.21e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TP53—urinary bladder cancer	3.12e-06	2.15e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTEN—urinary bladder cancer	3.02e-06	2.08e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—HRAS—urinary bladder cancer	2.98e-06	2.06e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—EP300—urinary bladder cancer	2.88e-06	1.98e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.67e-06	1.84e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.33e-06	1.61e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.22e-06	1.53e-05	CbGpPWpGaD
